Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
HighLife logo — Trans-septal Mitral Valve Replacement

HighLife

Trans-septal Mitral Valve Replacement

Founded 2010 France France 84 employees Series C Total: $48.30M Health Care, Medical Devices

General Information

Company Name HighLife
Founded Year 2010
Location France France
Employees 84
Industries Health Care, Medical Devices
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with HighLife. To contact HighLife, visit highlifemedical.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does HighLife compare?

A PDF of HighLife and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting HighLife soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About HighLife

HighLife is a France-based startup focused on trans-catheter mitral valve replacement. Established in 2010, the company is dedicated to leveraging minimally invasive technology to provide optimal solutions for patients in need. Operating in the Health Care and Medical Devices sectors, HighLife has recently received a Series C investment on 11 December 2020, with VI Partners participating as the lead investor. The firm's slogan, "Trans-septal Mitral Valve Replacement," encapsulates its core mission in a concise manner, emphasizing its commitment to pioneering advancements in the field.

Business keywords: Transcatheter Mitral Valve Replacement, Minimally Invasive Technology, Prosthetic Mitral Valve, Clinical Evaluation, Heart Valve Innovation, Medical Device, Cardiovascular Treatment, Beating Heart Surgery, Anatomical Preservation, Medical Technology, Innovation in Cardiology, Transcatheter Surgery, Mitral Valve Regurgitation, Ease of Use, Patient Safety

Services & Products

Innovative transcatheter solutions for mitral valve replacement

Target Customers

Patients with moderate to severe Mitral Regurgitation

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series C Undisclosed 1
VI Partners
VI Partners
11 Dec 2020
Series B $36.00M 5
Sofinnova Partners US Venture Partners Andera Partner
Sofinnova Partners, US Venture Partners +3
17 Jan 2019
Series A €12.30M 3
Sofinnova Partners
Sofinnova Partners, LivaNova +1
30 Oct 2017

HighLife Alternatives & Competitors

View All Alternatives
HighLife vs
Hanyu Medical
Hanyu Medical

Pioneering minimally invasive mitral valve repair solutions for effective heart disease treatment

Series D
1 employees
Health Care, Medical Devices
HighLife vs
Tioga Cardiovascular
Tioga Cardiovascular United States

Redefining heart valve replacement with simplified, minimally invasive transcatheter solutions for m...

Series C
11 employees
Health Care, Medical Devices
HighLife vs
JenaValve Technology, Inc.
JenaValve Technology, Inc. United States

Aortic regurgitation is different. So is our valve.

Series C
149 employees
Health Care, Manufacturing
Compare HighLife vs JenaValve Technology, Inc.
Also compare with: HighLife vs MVRx, Inc. MVRx, Inc. View all alternatives

FAQ About HighLife

Trans-septal Mitral Valve Replacement
HighLife was founded in 2010.
HighLife is headquartered in France.
HighLife operates in Health Care and Medical Devices. Its work centres on Transcatheter Mitral Valve Replacement, Minimally Invasive Technology, Prosthetic Mitral Valve and Clinical Evaluation. Its customers include Patients with moderate to severe Mitral Regurgitation.
HighLife has approximately 84 employees.
HighLife has completed 3 funding rounds, raising a total of $48.30M. The latest funding stage is Series C.
HighLife offers: Innovative transcatheter solutions for mitral valve replacement.
Top alternatives and competitors to HighLife include Hanyu Medical, Tioga Cardiovascular, JenaValve Technology, Inc., NeoChord, Inc., MVRx, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
HighLife and Hanyu Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for HighLife, https://bouncewatch.com/company/highlife, updated 9 April 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes